4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-101641
Chief Scientific Officer acquired 521 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Yocca Frank · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 1 in the form | +521 | 10,538 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-14 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −521 | 5,211 | D |
Loading xslF345X05/tm2326350-3_4seq1.xml…